Preliminary safety and biological efficacy studies of ethyl pyruvate in normal mature horses

Equine Veterinary Journal

Volumn 43, Issue 3, 2011, Pages 341-347

  Schroeder, E L ^a   Holcombe, S J ^a   Cook, V L ^a   James, M D ^a   Gandy, J C ^a   Hauptman, J G ^a   Sordillo, L M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Cytokine; Endotoxin; Ethyl pyruvate; Horse

Indexed keywords

LIPOPOLYSACCHARIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; ENDOTOXEMIA; FEMALE; GENE EXPRESSION; HEART RATE; HORSE; HORSE DISEASE; MALE; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; FEMALE; GENE EXPRESSION; HEART RATE; HORSE DISEASES; HORSES; LIPOPOLYSACCHARIDES; MALE; PYRUVATES;

CANIS FAMILIARIS; EQUIDAE; OVIS ARIES; RODENTIA; SUIDAE;

EID: 79954601372     PISSN: 04251644     EISSN: 20423306     Source Type: Journal    
DOI: 10.1111/j.2042-3306.2010.00214.x     Document Type: Article

References (30)

1. Barton, M.H. and Collatos, C. (1999) Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease. J. vet. intern. Med. 13, 457-464.
2. Bennett-Guerrero, E., Swaminathan, M., Grigore, A.M., Roach, G.W., Aberle, L.G., Johnston, J.M. and Fink, M.P. (2009) A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 23, 324-329.
3. Cai, B., Brunner, M., Wang, H., Wang, P., Deitch, E.A. and Ulloa, L. (2009a) Ethyl pyruvate improves survival in awake hemorrhage. J. Mol. Med. 87, 423-433.
4. Cai, B., Chen, F., Lin, X., Miller, E., Szabo, C., Deitch, E.A. and Ulloa, L. (2009b) Anti-inflammatory adjuvant in resuscitation fluids improves survival in hemorrhage. Crit. Care Med. 37, 860-868.
5. Chen, W., Jia, Z., Zhu, H., Li, Y. and Misra, H.P. (2009) Ethyl pyruvate inhibits peroxynitrite-induced DNA damage and hydroxyl radical generation: Implications for neuroprotection. Neurochem. Res. 35, 336-342.
6. Cruz, R.J., Harada, T., Sasatomi, E. and Fink, M.P. (2009) Effects of ethyl pyruvate and other α-keto carboxylic acid derivatives in a rat model of multivisceral ischemia and reperfusion. J. Surg. Res. Epub. DOI: 10.1016/j.jss.2009.07088.
7. Dong, W., Cai, B., Peña, G., Pisarenko, V., Vida, G., Doucet, D., Lee, M., Sharpe, S., Lu, Q., Xu, D.Z., Ramos, L., Deitch, E.A. and Ulloa, L. (2009) Ethyl pyruvate prevents inflammatory responses and organ damage during porcine hemorrhage. Shock 34, 205-213.
8. Fessler, J.F., Bottoms, G.D., Coppoc, G.L., Gimarc, S., Latshaw, H.S. and Noble, J.K. (1989) Plasma endotoxin concentrations in experimental and clinical equine subjects. Equine vet. J., Suppl. 21, 24-28.
9. Fink, M.P. (2001) Ringer's ethyl pyruvate solution: A novel resuscitation fluid. Minerva Anestesiol. 67, 190-192.
10. Fink, M.P. (2008) Ethyl pyruvate. Curr. Opin. Anaesthesiol. 21, 160-167.
11. Kao, K.K. and Fink, M.P. (2010) The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem. Pharmacol. 80, 151-159.
12. Karabeyoǧlu, M., Unal, B., Bozkurt, B., Bilgihan, A., Karabeyoǧlu, I. and Cengiz, O. (2008) The effect of ethyl pyruvate on oxidative stress in intestine and bacterial translocation after thermal injury. J. Surg. Res. 144, 59-63.
13. Kim, J.B., Yu, Y.M., Kim, S.W. and Lee, J.K. (2005) Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res. 1060, 188-192.
14. King, J.N. and Gerring, E.L. (1988) Detection of endotoxin in cases of equine colic. Vet. Rec. 123, 269-271.
15. Moore, J.N., White, N.A., Berg, J.N., Trim, C.M. and Garner, H.E. (1981) Endotoxemia following experimental intestinal strangulation obstruction in ponies. Can. J. comp. Med. 45, 330-332.
16. Moore, J.N., Norton, N., Barton, M.H., Hurley, D.J., Reber, A.J., Donovan, D.C., Vandenplas, M.L., Parker, T.S. and Levine, D.M. (2007) Rapid infusion of a phospholipid emulsion attenuates the effects of endotoxaemia in horses. Equine vet. J. 39, 243-248.
17. Morris, D.D. (1991) Endotoxemia in horses: A review of cellular and humoral mediators involved in its pathogenesis. J. vet. intern. Med. 5, 167-181.
18. Nieto, J.E., MacDonald, M.H., Braim, A.E. and Aleman, M. (2009) Effect of lipopolysaccharide infusion on gene expression of inflammatory cytokines in normal horses in vivo. Equine vet. J. 41, 717-719.
19. Pritchett, L.C., Ulibarri, C., Roberts, M.C., Schneider, R.K. and Sellon, D.C. (2003) Identification of potential physiological and behavioral indicators of postoperative pain in horses after exploratory celiotomy for colic. Appl. Anim. Behav. Sci. 80, 31-43.
20. Raetz, C.R. and Whitfield, C. (2002) Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635-700.
21. Sims, C.A., Wattanasirichaigoon, S., Menconi, M.J., Ajami A.M., and Fink M.P. (2001) Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit. Care Med. 29, 1513-1518.
22. Steverink, P.J., Salden, H.J., Sturk, A., Klein, W.R., van der Velden, M.A. and Németh, F. (1994) Laboratory and clinical evaluation of a chromogenic endotoxin assay for horses with acute intestinal disorders. Vet. Q. 16 ( Suppl 2 ), S117-S121.
23. Su, F., Wang, Z., Cai, Y., Remmelink, M. and Vincent, J.L. (2007) Beneficial effects of ethyl pyruvate in septic shock from peritonitis. Arch. Surg. 142, 166-171.
24. Tawadrous, Z.S., Delude, R.L. and Fink, M.P. (2002) Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock 17, 473-477.
25. Thoefner, M.B., Ersboll, A.K., Jensen, A.L. and Hesselholt, M. (2001) Factor analysis of the interrelationships between clinical variables in horses with colic. Prev. vet. Med. 48, 201-214.
26. Tomlinson, J.E. and Blikslager, A.T. (2004) Effects of ischemia and the cyclooxygenase inhibitor flunixin on in vitro passage of lipopolysaccharide across equine jejunum. Am. J. vet. Res. 65, 1377-1383.
27. Ulloa, L., Ochani, M., Yang, H., Tanovic, M., Halperin, D., Yang, R., Czura, C.J., Fink, M.P. and Tracey, K.J. (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. USA 99, 12351-12356.
28. Van Zoelen, M.A., de Vos, A.F., Larosa, G.J., Draing, C., von Aulock, S. and van der Poll, T. (2007) Intrapulmonary delivery of ethyl pyruvate attenuates lipopolysaccharide- and lipoteichoic acid-induced lung inflammation in vivo. Shock 28, 570-575.
29. Venkataraman, R., Kellum, J.A., Song, M. and Fink, M.P. (2002) Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock 18, 507-512.
30. Yang, R., Gallo, D.J., Baust, J.J., Uchiyama, T., Watkins, S.K., Delude, R.L. and Fink, M.P. (2002) Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G212-G221.